Global Induced Pluripotent Stem Cells (iPSCs) Market Research Report 2024(Status and Outlook)
Report Overview:
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
The Global Induced Pluripotent Stem Cells (iPSCs) Market Size was estimated at USD 115.31 million in 2023 and is projected to reach USD 231.28 million by 2029, exhibiting a CAGR of 12.30% during the forecast period.
This report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSCs) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Induced Pluripotent Stem Cells (iPSCs) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSCs) market in any manner.
Global Induced Pluripotent Stem Cells (iPSCs) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Market Segmentation (by Type)
Human iPSCs
Mouse iPSCs
Market Segmentation (by Application)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Induced Pluripotent Stem Cells (iPSCs) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
The Global Induced Pluripotent Stem Cells (iPSCs) Market Size was estimated at USD 115.31 million in 2023 and is projected to reach USD 231.28 million by 2029, exhibiting a CAGR of 12.30% during the forecast period.
This report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSCs) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Induced Pluripotent Stem Cells (iPSCs) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSCs) market in any manner.
Global Induced Pluripotent Stem Cells (iPSCs) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Market Segmentation (by Type)
Human iPSCs
Mouse iPSCs
Market Segmentation (by Application)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Induced Pluripotent Stem Cells (iPSCs) Market
- Overview of the regional outlook of the Induced Pluripotent Stem Cells (iPSCs) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Induced Pluripotent Stem Cells (iPSCs) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Induced Pluripotent Stem Cells (iPSCs)
1.2 Key Market Segments
1.2.1 Induced Pluripotent Stem Cells (iPSCs) Segment by Type
1.2.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales by Manufacturers (2019-2024)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Manufacturers (2019-2024)
3.3 Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Induced Pluripotent Stem Cells (iPSCs) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Induced Pluripotent Stem Cells (iPSCs) Sales Sites, Area Served, Product Type
3.6 Induced Pluripotent Stem Cells (iPSCs) Market Competitive Situation and Trends
3.6.1 Induced Pluripotent Stem Cells (iPSCs) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INDUCED PLURIPOTENT STEM CELLS (IPSCS) INDUSTRY CHAIN ANALYSIS
4.1 Induced Pluripotent Stem Cells (iPSCs) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Type (2019-2024)
6.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
6.4 Global Induced Pluripotent Stem Cells (iPSCs) Price by Type (2019-2024)
7 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Sales by Application (2019-2024)
7.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) by Application (2019-2024)
7.4 Global Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2024)
8 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SEGMENTATION BY REGION
8.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region
8.2 North America
8.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Fujifilm Holding Corporation (CDI)
9.1.1 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.1.4 Fujifilm Holding Corporation (CDI) Business Overview
9.1.5 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
9.1.6 Fujifilm Holding Corporation (CDI) Recent Developments
9.2 Ncardia
9.2.1 Ncardia Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.2.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.2.4 Ncardia Business Overview
9.2.5 Ncardia Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
9.2.6 Ncardia Recent Developments
9.3 Sumitomo Dainippon Pharma
9.3.1 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
9.3.5 Sumitomo Dainippon Pharma Business Overview
9.3.6 Sumitomo Dainippon Pharma Recent Developments
9.4 Astellas Pharma Inc
9.4.1 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.4.4 Astellas Pharma Inc Business Overview
9.4.5 Astellas Pharma Inc Recent Developments
9.5 Fate Therapeutics, Inc
9.5.1 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.5.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.5.4 Fate Therapeutics, Inc Business Overview
9.5.5 Fate Therapeutics, Inc Recent Developments
9.6 Pluricell Biotech
9.6.1 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.6.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.6.4 Pluricell Biotech Business Overview
9.6.5 Pluricell Biotech Recent Developments
9.7 Cell Inspire Biotechnology
9.7.1 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.7.4 Cell Inspire Biotechnology Business Overview
9.7.5 Cell Inspire Biotechnology Recent Developments
9.8 ReproCELL
9.8.1 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.8.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.8.4 ReproCELL Business Overview
9.8.5 ReproCELL Recent Developments
10 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET FORECAST BY REGION
10.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast
10.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country
10.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region
10.2.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Induced Pluripotent Stem Cells (iPSCs) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells (iPSCs) by Type (2025-2030)
11.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSCs) by Type (2025-2030)
11.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2025-2030)
11.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) Forecast by Application
11.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Induced Pluripotent Stem Cells (iPSCs)
1.2 Key Market Segments
1.2.1 Induced Pluripotent Stem Cells (iPSCs) Segment by Type
1.2.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales by Manufacturers (2019-2024)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Manufacturers (2019-2024)
3.3 Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Induced Pluripotent Stem Cells (iPSCs) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Induced Pluripotent Stem Cells (iPSCs) Sales Sites, Area Served, Product Type
3.6 Induced Pluripotent Stem Cells (iPSCs) Market Competitive Situation and Trends
3.6.1 Induced Pluripotent Stem Cells (iPSCs) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INDUCED PLURIPOTENT STEM CELLS (IPSCS) INDUSTRY CHAIN ANALYSIS
4.1 Induced Pluripotent Stem Cells (iPSCs) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Type (2019-2024)
6.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
6.4 Global Induced Pluripotent Stem Cells (iPSCs) Price by Type (2019-2024)
7 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Sales by Application (2019-2024)
7.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) by Application (2019-2024)
7.4 Global Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2024)
8 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SEGMENTATION BY REGION
8.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region
8.2 North America
8.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Fujifilm Holding Corporation (CDI)
9.1.1 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.1.4 Fujifilm Holding Corporation (CDI) Business Overview
9.1.5 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
9.1.6 Fujifilm Holding Corporation (CDI) Recent Developments
9.2 Ncardia
9.2.1 Ncardia Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.2.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.2.4 Ncardia Business Overview
9.2.5 Ncardia Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
9.2.6 Ncardia Recent Developments
9.3 Sumitomo Dainippon Pharma
9.3.1 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
9.3.5 Sumitomo Dainippon Pharma Business Overview
9.3.6 Sumitomo Dainippon Pharma Recent Developments
9.4 Astellas Pharma Inc
9.4.1 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.4.4 Astellas Pharma Inc Business Overview
9.4.5 Astellas Pharma Inc Recent Developments
9.5 Fate Therapeutics, Inc
9.5.1 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.5.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.5.4 Fate Therapeutics, Inc Business Overview
9.5.5 Fate Therapeutics, Inc Recent Developments
9.6 Pluricell Biotech
9.6.1 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.6.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.6.4 Pluricell Biotech Business Overview
9.6.5 Pluricell Biotech Recent Developments
9.7 Cell Inspire Biotechnology
9.7.1 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.7.4 Cell Inspire Biotechnology Business Overview
9.7.5 Cell Inspire Biotechnology Recent Developments
9.8 ReproCELL
9.8.1 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Basic Information
9.8.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Overview
9.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
9.8.4 ReproCELL Business Overview
9.8.5 ReproCELL Recent Developments
10 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET FORECAST BY REGION
10.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast
10.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country
10.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region
10.2.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Induced Pluripotent Stem Cells (iPSCs) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells (iPSCs) by Type (2025-2030)
11.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSCs) by Type (2025-2030)
11.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2025-2030)
11.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) Forecast by Application
11.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Region (M USD)
Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2022)
Table 10. Global Market Induced Pluripotent Stem Cells (iPSCs) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Induced Pluripotent Stem Cells (iPSCs) Sales Sites and Area Served
Table 12. Manufacturers Induced Pluripotent Stem Cells (iPSCs) Product Type
Table 13. Global Induced Pluripotent Stem Cells (iPSCs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Induced Pluripotent Stem Cells (iPSCs)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Induced Pluripotent Stem Cells (iPSCs) Market Challenges
Table 22. Global Induced Pluripotent Stem Cells (iPSCs) Sales by Type (Kilotons)
Table 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (M USD)
Table 24. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Type (2019-2024)
Table 26. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) by Type (2019-2024)
Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Type (2019-2024)
Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) by Application
Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
Table 31. Global Induced Pluripotent Stem Cells (iPSCs) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application (2019-2024)
Table 33. Global Induced Pluripotent Stem Cells (iPSCs) Sales by Application (2019-2024) & (M USD)
Table 34. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2024)
Table 35. Global Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2024)
Table 36. Global Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region (2019-2024)
Table 38. North America Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2024) & (Kilotons)
Table 43. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 44. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 45. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Fujifilm Holding Corporation (CDI) Business Overview
Table 47. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 48. Fujifilm Holding Corporation (CDI) Recent Developments
Table 49. Ncardia Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 50. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 51. Ncardia Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ncardia Business Overview
Table 53. Ncardia Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 54. Ncardia Recent Developments
Table 55. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 56. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 57. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 59. Sumitomo Dainippon Pharma Business Overview
Table 60. Sumitomo Dainippon Pharma Recent Developments
Table 61. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 62. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 63. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Astellas Pharma Inc Business Overview
Table 65. Astellas Pharma Inc Recent Developments
Table 66. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 67. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 68. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Fate Therapeutics, Inc Business Overview
Table 70. Fate Therapeutics, Inc Recent Developments
Table 71. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 72. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 73. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Pluricell Biotech Business Overview
Table 75. Pluricell Biotech Recent Developments
Table 76. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 77. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 78. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Cell Inspire Biotechnology Business Overview
Table 80. Cell Inspire Biotechnology Recent Developments
Table 81. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 82. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 83. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ReproCELL Business Overview
Table 85. ReproCELL Recent Developments
Table 86. Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Induced Pluripotent Stem Cells (iPSCs) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Region (M USD)
Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2022)
Table 10. Global Market Induced Pluripotent Stem Cells (iPSCs) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Induced Pluripotent Stem Cells (iPSCs) Sales Sites and Area Served
Table 12. Manufacturers Induced Pluripotent Stem Cells (iPSCs) Product Type
Table 13. Global Induced Pluripotent Stem Cells (iPSCs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Induced Pluripotent Stem Cells (iPSCs)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Induced Pluripotent Stem Cells (iPSCs) Market Challenges
Table 22. Global Induced Pluripotent Stem Cells (iPSCs) Sales by Type (Kilotons)
Table 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (M USD)
Table 24. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Type (2019-2024)
Table 26. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) by Type (2019-2024)
Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Type (2019-2024)
Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) by Application
Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
Table 31. Global Induced Pluripotent Stem Cells (iPSCs) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application (2019-2024)
Table 33. Global Induced Pluripotent Stem Cells (iPSCs) Sales by Application (2019-2024) & (M USD)
Table 34. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2024)
Table 35. Global Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2024)
Table 36. Global Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region (2019-2024)
Table 38. North America Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2024) & (Kilotons)
Table 43. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 44. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 45. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Fujifilm Holding Corporation (CDI) Business Overview
Table 47. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 48. Fujifilm Holding Corporation (CDI) Recent Developments
Table 49. Ncardia Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 50. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 51. Ncardia Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ncardia Business Overview
Table 53. Ncardia Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 54. Ncardia Recent Developments
Table 55. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 56. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 57. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 59. Sumitomo Dainippon Pharma Business Overview
Table 60. Sumitomo Dainippon Pharma Recent Developments
Table 61. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 62. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 63. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Astellas Pharma Inc Business Overview
Table 65. Astellas Pharma Inc Recent Developments
Table 66. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 67. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 68. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Fate Therapeutics, Inc Business Overview
Table 70. Fate Therapeutics, Inc Recent Developments
Table 71. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 72. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 73. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Pluricell Biotech Business Overview
Table 75. Pluricell Biotech Recent Developments
Table 76. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 77. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 78. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Cell Inspire Biotechnology Business Overview
Table 80. Cell Inspire Biotechnology Recent Developments
Table 81. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 82. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 83. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ReproCELL Business Overview
Table 85. ReproCELL Recent Developments
Table 86. Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Induced Pluripotent Stem Cells (iPSCs) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Induced Pluripotent Stem Cells (iPSCs)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD), 2019-2030
Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) (2019-2030)
Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (M USD)
Figure 11. Induced Pluripotent Stem Cells (iPSCs) Sales Share by Manufacturers in 2023
Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Manufacturers in 2023
Figure 13. Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Induced Pluripotent Stem Cells (iPSCs) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type
Figure 18. Sales Market Share of Induced Pluripotent Stem Cells (iPSCs) by Type (2019-2024)
Figure 19. Sales Market Share of Induced Pluripotent Stem Cells (iPSCs) by Type in 2023
Figure 20. Market Size Share of Induced Pluripotent Stem Cells (iPSCs) by Type (2019-2024)
Figure 21. Market Size Market Share of Induced Pluripotent Stem Cells (iPSCs) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application
Figure 24. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application (2019-2024)
Figure 25. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application in 2023
Figure 26. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2024)
Figure 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application in 2023
Figure 28. Global Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region (2019-2024)
Figure 30. North America Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 32. U.S. Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Induced Pluripotent Stem Cells (iPSCs) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 37. Germany Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region in 2023
Figure 44. China Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (Kilotons)
Figure 50. South America Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 51. Brazil Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2025-2030)
Figure 65. Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Application (2025-2030)
Figure 66. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Induced Pluripotent Stem Cells (iPSCs)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD), 2019-2030
Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) (2019-2030)
Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (M USD)
Figure 11. Induced Pluripotent Stem Cells (iPSCs) Sales Share by Manufacturers in 2023
Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Manufacturers in 2023
Figure 13. Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Induced Pluripotent Stem Cells (iPSCs) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type
Figure 18. Sales Market Share of Induced Pluripotent Stem Cells (iPSCs) by Type (2019-2024)
Figure 19. Sales Market Share of Induced Pluripotent Stem Cells (iPSCs) by Type in 2023
Figure 20. Market Size Share of Induced Pluripotent Stem Cells (iPSCs) by Type (2019-2024)
Figure 21. Market Size Market Share of Induced Pluripotent Stem Cells (iPSCs) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application
Figure 24. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application (2019-2024)
Figure 25. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application in 2023
Figure 26. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2024)
Figure 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application in 2023
Figure 28. Global Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region (2019-2024)
Figure 30. North America Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 32. U.S. Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Induced Pluripotent Stem Cells (iPSCs) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Induced Pluripotent Stem Cells (iPSCs) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 37. Germany Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region in 2023
Figure 44. China Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (Kilotons)
Figure 50. South America Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 51. Brazil Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2025-2030)
Figure 65. Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Application (2025-2030)
Figure 66. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2025-2030)
